Healthcare Insights

Image related to an article about GSK

GSK (LON:GSK) price about to hit new 52-week high

Healthcare

The good news for any holders of GSK (LON:GSK) is that the price is currently trading close to a 52 week high, with the share price up by around 2.45% to 1,737p over the past week.  For investors holding the stock (or considering buyin...

LON:GSK

Image related to an article about Medica

Is Medica well placed to resist volatility?

Healthcare

An important question for small-cap investors right now is whether the current geopolitical and economic uncertainty will affect the share prices of companies like Medica. The stock is currently trading at 158p, but to predict how the...

LON:MGP^G23

Image related to an article about Sierra Oncology

Sierra Oncology hits 52w high – but will it continue?

Healthcare

It's a good time to be a shareholder in Sierra Oncology (NMQ:SRRA) - as the share approaches its 52-week high, holders may be wondering whether to sell and take the profit, or buy more and ride the uptrend. Shares in Sierra Oncology ar...

NMQ:SRRA^G22

Image related to an article about UFP Technologies

UFP Technologies share price hits a one-year high

Healthcare

Shares in UFP Technologies (NAQ:UFPT) are currently trading close to a 52 week high, with the share price up by around 3.37% to $81.3 over the past week. On a one-month basis, the UFP Technologies price has risen by 13.3%. For investor...

NAQ:UFPT

Image related to an article about HUTCHMED (China)

Which way now for the HUTCHMED (China) share price?

Healthcare

Geopolitical and economic turmoil has changed the outlook for companies across all industry sectors. For investors who own shares in them, the question now is whether these stocks are worth holding and where their prices will go from h...

LON:HCM

Image related to an article about Genus

What do city experts think about the outlook for Genus?

Healthcare

Broker recommendations can be a useful early clue in the hunt for stocks to add to your portfolio. These city analysts know the companies they cover better than most, so their views on whether to buy or sell them are worth considering....

LON:GNS

Image related to an article about CVS

Analysts optimistic on CVS outlook

Healthcare

The CVS (LON:CVSG) share price has risen by 8.86% over the past month and it’s currently trading at 1,770p. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue. Acc...

LON:CVSG

  • Quality
    76
  • Value
    83
  • Momentum
    68
  • StockRank™
    93

Unlock comprehensive stock market insights

Quickly sanity-check any investment idea, with a free trial of Stockopedia's award-winning research platform. Join over 15,000 investors who use Stockopedia to:

  • Access institutional-quality insights on thousands of stocks
  • Make more confident, successful investing decisions
  • Learn from the smartest investor community on the web
Get started for free

Absolutely Perfect

"Trialed multiple other platforms - this is by far my favourite. Other platforms do not even have half the stuff that you can find on Stockopedia. Love it!"